<?xml version="1.0" encoding="UTF-8"?>
<results title="virus">
 <result pre="history and potential for drug discovery of hepatitis C virus," exact="dengue virus," post="respiratory syncytial virus, Ebola virus and norovirus replicon and"/>
 <result pre="hepatitis C virus (HCV) and then illustrate the potential of" exact="dengue virus," post="togavirus, respiratory syncytial virus and norovirus replicons, and the"/>
 <result pre="neomycin resistance cassette. Expression of NS3–NS5B was driven by the" exact="encephalomyocarditis virus" post="(EMCV) internal ribosome entry site (IRES), establishing a bicistronic"/>
 <result pre="(bi) and its derived replicons (bii and iii). Replicons for" exact="dengue virus" post="have been produced by replacement of the C-terminal part"/>
 <result pre="It is estimated that 390 million people are infected with" exact="dengue virus" post="every year. Despite a high proportion of infections being"/>
 <result pre="date, there is no approved specific drug treatment available against" exact="dengue virus" post="[38]. Dengue virus has a single-stranded, positive-sense RNA genome"/>
 <result pre="established for closely related viruses like Kunjin, West Nile and" exact="yellow fever virus" post="17, 41, 42. In 2011, selectable DENV replicons harbouring"/>
 <result pre="Nile virus drug discoveryAntimicrob. Agents Chemother.4920054980498816304161 16KaplanG.RacanielloV.R.Construction and characterization of" exact="poliovirus" post="subgenomic repliconsJ. Virol.621988168716962833619 17KhromykhA.A.WestawayE.G.Subgenomic replicons of the flavivirus Kunjin:"/>
 <result pre="and 3’ untranslated regions of the flaviviral genomeViruses9201710.3390/v9060137 40PangX.Development of" exact="dengue virus" post="type 2 replicons capable of prolonged expression in host"/>
 <result pre="York strain of West Nile virusVirology296200221923312069521 42JonesC.T.Construction and applications of" exact="yellow fever virus" post="repliconsVirology331200524725915629769 43LeardkamolkarnV.Development of dengue type-2 virus replicons expressing GFP"/>
 <result pre="44ManzanoM.Identification of cis-acting elements in the 3’-untranslated region of the" exact="dengue virus" post="type 2 RNA that modulate translation and replicationJ. Biol."/>
 <result pre="replicationJ. Biol. Chem.2862011225212253421515677 45NgC.Y.Construction and characterization of a stable subgenomic" exact="dengue virus" post="type 2 replicon system for antiviral compound and siRNA"/>
 <result pre="optimization of phthalazinone derivatives as a new class of potent" exact="dengue virus" post="inhibitorsEur. J. Med. Chem.145201832833729335200 48FrabasileS.The citrus flavanone naringenin impairs"/>
 <result pre="virus inhibitorsEur. J. Med. Chem.145201832833729335200 48FrabasileS.The citrus flavanone naringenin impairs" exact="dengue virus" post="replication in human cellsSci. Rep.720174186428157234 49Hernandez-MoralesI.Characterization of a dengue"/>
 <result pre="target for antiviral interventionRev. Med. Virol.25201520522325828437 51ZanelloP.R.Quinic acid derivatives inhibit" exact="dengue virus" post="replication in vitroVirol. J.12201522326695767 52HishikiT.Hirsutine, an indole alkaloid of"/>
 <result pre="an indole alkaloid of uncaria rhynchophylla, inhibits late step in" exact="dengue virus" post="lifecycleFront. Microbiol.82017167428912773 53DigheS.N.Recent update on anti-dengue drug discoveryEur. J."/>
 <result pre="4’-chloromethyl-2’-deoxy-3’,5’-di-O-isobutyryl-2’-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of" exact="human respiratory syncytial virus" post="infectionJ. Med. Chem.5820151862187825667954 83J&amp;amp;J Takes $900 Million Loss as"/>
 <result pre="the human metapneumovirus, from cloned cDNAMethods Mol. Biol.1602201712513928508218 115KalhoroN.H.A recombinant" exact="vesicular stomatitis virus" post="replicon vaccine protects chickens from highly pathogenic avian influenza"/>
</results>
